Literature DB >> 21908062

The economic burden of type 2 diabetes mellitus in rural southwest China.

Cai Le1, Li Lin, Dong Jun, He Jianhui, Zhao Keying, Cui Wenlong, Song Ying, Wei Tao.   

Abstract

BACKGROUND: This study was conducted in order to estimate the economic burden of diabetes in a given year in rural Yunnan province of China, including direct, indirect and intangible costs.
METHODS: A cross-sectional survey was conducted in rural southwest China in early 2011 among 9396 consenting individuals aged ≥ 18 years. Information on participants' demographic characteristics, and economic consequences and related aspects of diabetes were obtained using a standard questionnaire. Fasting blood sugar level was also measured for each individual. Years of life lost (YLL) due to diabetes was estimated using medical death certificates. A prevalence-based cost-of-illness method was used to estimate the economic burden of diabetes.
RESULTS: The overall prevalence and YLL of diabetes was 6.5% and 1168.1 years in the study population, respectively. Total cost of illness related to diabetes was estimated to be $46.8 million. Mean unit direct medical costs, direct non-medical costs, morbidity costs, mortality costs, intangible costs, and cost of illness were $863.2, $44.6, $59.7, $7797.7, $936.2, and $9686.6, respectively. Direct costs accounted for the largest proportion of the economic costs of diabetes. Age was positively associated with direct costs whereas negatively associated with indirect costs. Patients aged 45-59 years incurred the highest intangible costs. Both indirect and intangible costs increased with level of education.
CONCLUSIONS: Diabetes is a major public health problem in terms of morbidity and economic burden in rural southwest China. The region should increase investment in the further control of diabetes, and improvement of patient quality of life.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908062     DOI: 10.1016/j.ijcard.2011.08.039

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina.

Authors:  Jorge F Elgart; Santiago Asteazarán; Jorge L De La Fuente; Cecilia Camillucci; Jonathan B Brown; Juan José Gagliardino
Journal:  Int J Public Health       Date:  2014-09-05       Impact factor: 3.380

Review 2.  The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.

Authors:  Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-01-18       Impact factor: 8.082

Review 3.  Socioeconomic status and prevalence of type 2 diabetes in mainland China, Hong Kong and Taiwan: a systematic review.

Authors:  Hongjiang Wu; Xiangrui Meng; Sarah H Wild; Danijela Gasevic; Caroline A Jackson
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413

4.  Direct and indirect costs of diabetes mellitus in Mali: A case-control study.

Authors:  Clara Bermudez-Tamayo; Stéphane Besançon; Mira Johri; Sidibe Assa; Jonathan Betz Brown; Kaushik Ramaiya
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

5.  Evaluating Health Co-Benefits of Climate Change Mitigation in Urban Mobility.

Authors:  Brigitte Wolkinger; Willi Haas; Gabriel Bachner; Ulli Weisz; Karl Steininger; Hans-Peter Hutter; Jennifer Delcour; Robert Griebler; Bernhard Mittelbach; Philipp Maier; Raphael Reifeltshammer
Journal:  Int J Environ Res Public Health       Date:  2018-04-28       Impact factor: 3.390

6.  The costs of diabetes treatment in low- and middle-income countries: a systematic review.

Authors:  Corrina Moucheraud; Cosima Lenz; Michaella Latkovic; Veronika J Wirtz
Journal:  BMJ Glob Health       Date:  2019-02-27

Review 7.  Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples.

Authors:  Lan Gao; Hao Hu; Fei-Li Zhao; Shu-Chuen Li
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

8.  Metabolic Risk Factors of Type 2 Diabetes Mellitus and Correlated Glycemic Control/Complications: A Cross-Sectional Study between Rural and Urban Uygur Residents in Xinjiang Uygur Autonomous Region.

Authors:  Guo-Li Du; Yin-Xia Su; Hua Yao; Jun Zhu; Qi Ma; Ablikm Tuerdi; Xiao-Dong He; Li Wang; Zhi-Qiang Wang; Shan Xiao; Shu-Xia Wang; Li-Ping Su
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

9.  Comparing the Economic Burden of Type 2 Diabetes Mellitus Patients with and without Medical Insurance: A Cross-Sectional Study in China.

Authors:  Chao Yang; Zhe Huang; Kexin Sun; Yonghua Hu; Xiaoyuan Bao
Journal:  Med Sci Monit       Date:  2018-05-12

10.  Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data.

Authors:  Haibin Wu; Karen N Eggleston; Jieming Zhong; Ruying Hu; Chunmei Wang; Kaixu Xie; Yiwei Chen; Xiangyu Chen; Min Yu
Journal:  J Diabetes Investig       Date:  2018-08-17       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.